Glenn W. Welling
Engaged Capital
Glenn W. Welling MEDIFAST INC stake
total: 101
Engaged Capital MED trades
- Total transactions:
- 17
- New positions:
- 3
- Sold out:
- 3
- Added:
- 8
- Reduced:
- 3
- Held since:
- 2019 Q3
- Held for:
- 5 quarters
- Latest activity:
- 2020 Q4
According to 2026 Q2 report, Glenn W. Welling doesn't hold any MEDIFAST INC (MED) shares. To date, the estimated cost basis is nearly $106.95 for "buy" trades and estimated average "sell" price is $164.45. Engaged Capital first purchased MED in 2014 Q1, initially acquiring 600,000 shares. Glenn W. Welling later completely sold out the position and invested in MEDIFAST INC again in 2019 Q3. Since the initial investment in MEDIFAST INC (MED), Engaged Capital has made 16 more transactions.
When did Glenn W. Welling sell MEDIFAST INC (MED)?
Glenn W. Welling sold off the entire MEDIFAST INC (MED) position in 2020 Q4.
When did Glenn W. Welling buy MEDIFAST INC (MED)?
Glenn W. Welling first invested in MEDIFAST INC (MED) in 2014 Q1 at the reported quarter-end price of $29.09 per share.
What's the cost basis of Engaged Capital's MED stake?
The estimated cost basis for MEDIFAST INC (MED) stake is around $106.95 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $106.95
- Weighted AVG sell price:
- $164.45
Glenn W. Welling's historical trades in MEDIFAST INC
17 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2020 Q4
|
0.00%
|
$164.45
|
-100% (-267,543)
|
|||
|
2020 Q3
|
4.55%
|
$164.45
|
-76.94% (-892,833)
|
|||
|
2019 Q4
|
13.21%
|
$109.58
|
+126.40% (+647,853)
|
|||
|
2019 Q3
|
6.73%
|
$103.63
|
new
|
|||
|
2019 Q2
|
0.00%
|
$127.56
|
-100% (-11,242)
|
|||
|
2019 Q1
|
0.20%
|
$127.56
|
new
|
|||
|
2018 Q1
|
0.00%
|
$69.81
|
-100% (-264,549)
|
|||
|
2017 Q4
|
2.34%
|
$69.81
|
-66.49% (-525,000)
|
|||
|
2017 Q1
|
8.89%
|
$44.37
|
+2.21% (+17,084)
|
|||
|
2016 Q4
|
10.48%
|
$41.63
|
+4.75% (+35,000)
|
|||
|
2015 Q3
|
11.36%
|
$26.86
|
+0.16% (+1,199)
|
|||
|
2015 Q2
|
13.69%
|
$32.32
|
+19.01% (+117,596)
|
|||
|
2015 Q1
|
13.84%
|
$29.97
|
+1.15% (+7,061)
|
|||
|
2014 Q4
|
16.75%
|
$33.55
|
+4.02% (+23,609)
|
|||
|
2014 Q3
|
14.27%
|
$32.83
|
+5.38% (+30,000)
|
|||
|
2014 Q2
|
11.77%
|
$30.41
|
-7.00% (-42,000)
|
|||
|
2014 Q1
|
11.98%
|
$29.09
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.